Bring the question that sent you searching. Ask the doctor or other person treating you how the proposed care would help with that concern.
Start with the concern, rather than a product name. Have the person providing your care describe the next step in words you can say back.
Ask whether studies in people support the treatment for your particular problem. Ask what those studies found and what they could not answer.
Compounding means preparing medicine for an order instead of supplying a finished product from a factory.
Drug products are reviewed by a US agency, the Food and Drug Administration (FDA).
As of September 2026, medicines prepared to order lack FDA approval. Before sale, FDA does not assess their safety, how well they work or the quality of their preparation.
Ask what medical need an approved product would leave unmet.
FDA: what it checks before a medicine is soldBPC-157 names one peptide. A peptide joins tiny chemical parts in a short string, like beads; proteins use those same parts.
The name does not explain what it could repair. Ask what benefit is expected for your problem and what studies support that use.
FDA records checked as of September 2026 show no US drug approval for BPC-157.
As of September 2026, FDA lacked enough human safety information to judge harm from the proposed ways of using BPC-157.
Ask the person treating you to name the exact medicine, explain whether it is approved, and describe the studies supporting its use.
FDA: read the ingredient-specific concernsAsk which visits and tests the proposed plan involves, then ask for a written cost breakdown. Bring any unanswered insurance question back to the discussion.